First Oral Drug for Moderate-To-Severe Ulcerative Colitis

被引:0
|
作者
Aschenbrenner, Diane S.
机构
关键词
D O I
暂无
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Immediate-release tofacitinib (Xeljanz) is now approved to treat moderate-to-severe ulcerative colitis. Nurses should assess patients for infections prior to the initiation of and throughout tofacitinib treatment.
引用
收藏
页码:22 / 22
页数:1
相关论文
共 50 条
  • [31] Induction and Maintenance of Clinical Remission by Adalimumab in Patients With Moderate-to-Severe Ulcerative Colitis
    Sandborn, William J.
    Van Assche, Gert A.
    Reinisch, Walter
    Colombel, Jean-Frederic
    D'Haens, Geert R.
    Wolf, Douglas C.
    Kron, Martina
    Tighe, Mary Beth
    Lazar, Andreas
    Thakkar, Roopal
    [J]. GASTROENTEROLOGY, 2011, 140 (05) : S123 - S124
  • [32] Integrating novel therapies into the management of moderate-to-severe ulcerative colitis: challenges and opportunities
    Ma, Christopher
    Choi, May Y.
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (02): : 110 - 112
  • [33] Subcutaneous Golimumab Maintains Clinical Response in Patients With Moderate-to-Severe Ulcerative Colitis
    Sandborn, William J.
    Feagan, Brian G.
    Marano, Colleen
    Zhang, Hongyan
    Strauss, Richard
    Johanns, Jewel
    Adedokun, Omoniyi J.
    Guzzo, Cynthia
    Colombel, Jean-Frederic
    Reinisch, Walter
    Gibson, Peter R.
    Collins, Judith
    Jarnerot, Gunnar
    Rutgeerts, Paul
    [J]. GASTROENTEROLOGY, 2014, 146 (01) : 96 - +
  • [34] The role of vedolizumab in patients with moderate-to-severe Crohn's disease and ulcerative colitis
    Shahidi, Neal
    Bressler, Brian
    Panaccione, Remo
    [J]. THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2016, 9 (03) : 330 - 338
  • [35] Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis
    Sandborn, William J.
    van Assche, Gert
    Reinisch, Walter
    Colombel, Jean-Frederic
    D'Haens, Geert
    Wolf, Douglas C.
    Kron, Martina
    Tighe, Mary Beth
    Lazar, Andreas
    Thakkar, Roopal B.
    [J]. GASTROENTEROLOGY, 2012, 142 (02) : 257 - +
  • [36] An overview of ozanimod as a therapeutic option for adults with moderate-to-severe active ulcerative colitis
    Rowan, Catherine
    Ungaro, Ryan
    Mehandru, Saurabh
    Colombel, Jean-Frederic
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2022, 23 (08) : 893 - 904
  • [37] Induction with infliximab and a plant-based diet as first-line (IPF) therapy for moderate-to-severe to severe ulcerative colitis
    Chiba, Mitsuro
    Nakane, Kunio
    Tsuji, Tsuyotoshi
    Tsuda, Satoko
    Ishii, Hajime
    Ohno, Hideo
    Watanabe, Kenta
    Ito, Mai
    Obara, Yu
    Komatsu, Masafumi
    Sugawara, Takeshi
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 483 - 483
  • [38] Peficitinib, an Oral Janus Kinase Inhibitor, in Moderate-to-severe Ulcerative Colitis: Results From a Randomised, Phase 2 Study
    Sands, Bruce E.
    Sandborn, William J.
    Feagan, Brian G.
    Lichtenstein, Gary R.
    Zhang, Hongyan
    Strauss, Richard
    Szapary, Philippe
    Johanns, Jewel
    Panes, Julian
    Vermeire, Severine
    O'Brien, Christopher D.
    Yang, Zijiang
    Bertelsen, Kirk
    Marano, Colleen
    [J]. JOURNAL OF CROHNS & COLITIS, 2018, 12 (10): : 1158 - 1169
  • [39] Oral Ritlecitinib and Brepocitinib for Moderate-to-Severe Ulcerative Colitis: Results From a Randomized, Phase 2b Study
    Sandborn, William J.
    Danese, Silvio
    Leszczyszyn, Jaroslaw
    Romatowski, Jacek
    Altintas, Engin
    Peeva, Elena
    Hassan-Zahraee, Mina
    Vincent, Michael S.
    Reddy, Padmalatha S.
    Banfield, Christopher
    Salganik, Mikhail
    Banerjee, Anindita
    Gale, Jeremy D.
    Hung, Kenneth E.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (10) : 2616 - 2628
  • [40] Peripheral Blood DNA Methylation Signatures and Response to Tofacitinib in Moderate-to-severe Ulcerative Colitis
    Joustra, Vincent
    Li Yim, Andrew Y. F.
    van Gennep, Sara
    Hageman, Ishtu
    de Waard, Tristan
    Levin, Evgeni
    Lauffer, Peter
    de Jonge, Wouter
    Henneman, Peter
    Loewenberg, Mark
    D'Haens, Geert
    [J]. JOURNAL OF CROHNS & COLITIS, 2023, 18 (08): : 1179 - 1189